A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2006
11/08/2006	CN1283306C Traditional Chinese medicine capsule for treating tuberculosis and neo-last-cough
11/08/2006	CN1283298C Pharmaceutical composition for treating acute myocardial ischemia its preparing method
11/08/2006	CN1283297C Health care tea for nourishing lung and arresting cough
11/08/2006	CN1283296C Gorge caring tea and its preparing process
11/08/2006	CN1283278C Processing technique of Aconitum Carrnichaeli Debx
11/08/2006	CN1283273C Medicine for treating chicken respiratory tract disease
11/08/2006	CN1283269C Compound preparation of forest frog, and preparation method
11/08/2006	CN1283268C Compound dandelion freeze dried powder injection and its preparation method
11/08/2006	CN1283265C Oral medicine for treating dyspneic cough and its production process
11/08/2006	CN1283263C Medicine for treating rhinitis and its preparing process
11/08/2006	CN1283259C Iodine microsphere clathrate compound and its preparation method and uses
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006	US7132399 Mammalian cell surface DNA receptor
11/07/2006	US7132395 Contacting human rhinovirus with a polypeptide having a fragment of human rhinovirus major receptor (HRR) permit HRV to bind to the polypeptide; HRV is inhibited from infecting host cell.
11/07/2006	US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006	US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/02/2006	WO2006115509A2 Small molecule immunopotentiators and assays for their detection
11/02/2006	WO2006115247A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR
11/02/2006	WO2006115245A1 4-ethynylisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115244A1 4-bromoisoquinoline derivative and pharmaceutical preparation comprising the same
11/02/2006	WO2006115221A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006114379A1 Combination of medicaments to be inhaled, containing a betamimetic agent and a steroid in addition to an anticholinergic agent
11/02/2006	WO2006114054A1 Use of amorphophallus rivieri durieu and extract thereof in the manufacture of a medicament for treating acute, chronic bronchitis
11/02/2006	WO2006087077A3 Hsp90-inhibiting triazole derivatives
11/02/2006	WO2006077012A3 USE OF LXR LIGANDS FOR THE MODULATION OF DENDRITIC CELLS (DCs)
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	US20060246066 Cleavable reagents for specific delivery to disease sites
11/02/2006	US20060243276 Methods for treating rhinitis and conjunctivitis
11/02/2006	EP1716860A1 Preventive and therapeutic agent for chronic obstructive pulmonary disease
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716160A2 Novel inhibitors of chymase
11/02/2006	EP1716133A1 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
11/02/2006	EP1716123A1 Pyridazinone derivatives and their use as pde4 inhibitors
11/02/2006	EP1715860A1 Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases
11/02/2006	EP1715859A1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
11/02/2006	EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP1296923B1 Aspirin-triggered lipid mediators
11/02/2006	EP1276760B1 Polyamide nucleic acid derivatives, agents and methods for producing them
11/02/2006	EP1250313B1 Monohydrate of cis-lithium-cyano-4- 3-(cyclopentyloxy)-4-methoxyphenyl\|cyclohexanecarboxylate
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1017822B1 Lkta deletion mutant of p. haemolytica
11/02/2006	EP0719331B1 Eotaxin = eosinophil chemotactic cytokine
11/02/2006	CA2607391A1 Combination of medicaments to be inhaled, containing a betamimetic agent and a steroid in addition to an anticholinergic agent
11/02/2006	CA2605594A1 Heterocyclic compound
11/02/2006	CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006	CA2571710A1 Small molecule immunopotentiators and assays for their detection
11/01/2006	CN1856465A Amino-substituted ethylamino beta2 adrenergic receptor agonists
11/01/2006	CN1856325A Treatment of respiratory diseases with anti-IL-2 receptor antibodies
11/01/2006	CN1856317A Production method of an ivy leaf extract and extract prepared with same
11/01/2006	CN1856314A Farmaceutiske kombinationer af adenosin A-2a- og beta-2-adrenerge receptoragonister
11/01/2006	CN1854284A Vinegar with cough-preventing function
11/01/2006	CN1854131A Compounds and method for preparing sustituted 4-phenyl-4-cyanocyclohexanoic acids
11/01/2006	CN1853697A Use of konjak and its extract in preparation of medicine for treating acute and chronic bronchitis
11/01/2006	CN1853685A Pearl guttural tablets
11/01/2006	CN1853684A Composition containing pearl and its use
11/01/2006	CN1853657A Use of three chromium-enriched biological materials in medicine for treating allergic rhinitis
11/01/2006	CN1853639A Medical use of surface active substance
11/01/2006	CN1853632A Herba fibraurae recisae soft capsules and production thereof
11/01/2006	CN1282748C Method for preparing leukocyte interferon of pig
11/01/2006	CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same
11/01/2006	CN1282636C Vitamin D analogues
11/01/2006	CN1282465C Injection liquid in use for intravenous injection and preparation method
10/2006
10/31/2006	US7130692 Portable electrotherapy device for treating osteoarthritis and other diseases, defects and injuries of the knee joint
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129253 Compounds
10/31/2006	US7129246 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006	US7129222 Immunomodulatory formulations and methods for use thereof
10/31/2006	US7129077 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder
10/31/2006	US7128897 Having surface tension, effective for therapy of respiratory systme disorders
10/31/2006	CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006	CA2333405C Spill resistant pharmaceutical compositions
10/31/2006	CA2329217C Stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
10/31/2006	CA2276455C Phthalazinones
10/31/2006	CA2276310C Process for the production of tetrazolylbenzopyrans
10/31/2006	CA2262906C Novel immunotherapeutic agents and their use in the reduction of cytokine levels
10/31/2006	CA2186508C Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
10/26/2006	WO2006113448A1 Pharmacological treatment for sleep apnea

1 ... 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 ... 878